Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference
Creator Laurent et al.
Author Pierre-Antoine Laurent
Author Fabrice André
Author Alexandre Bobard
Author Sandra Demaria
Author Stephane Depil
Author Stefan B. Eichmüller
Author Cristian Fernandez-Palomo
Author Floris Foijer
Author Lorenzo Galluzzi
Author Matthias Guckenberger
Author Kevin J. Harrington
Author Fernanda G. Herrera
Author Peter E. Huber
Author Antoine Italiano
Author Sana D. Karam
Author Guido Kroemer
Author Philippe Lambin
Author Carola Leuschner
Author Alberto Mantovani
Author Etienne Meylan
Author Michele Mondini
Author Mikael J. Pittet
Author Jean-Pierre Pouget
Author Jordi Remon
Author Claus S. Sørensen
Author Christos Sotiriou
Author Claire Vanpouille-Box
Author Ralph R. Weichselbaum
Author James W. Welsh
Author Laurence Zitvogel
Author Silvia C. Formenti
Author Eric Deutsch
Abstract Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the gap between preclinical outcomes and clinical opportunities. Thus, it paves a promising way toward optimizing radiotherapy-immunotherapy combinations and, from a broader perspective, improving therapeutic strategies for patients with cancer. Herein, we report on the topics developed by key-opinion leaders during the 7th Immunorad Conference held in Paris-Les Cordeliers (France) from September 27th to 29th 2023, and set the stage for the 8th edition of Immunorad which will be held at Weill Cornell Medical College (New-York, USA) in October 2024.
Publication Oncoimmunology
Volume 14
Issue 1
Pages 2432726
Date 2025-12
Journal Abbr Oncoimmunology
Language eng
DOI 10.1080/2162402X.2024.2432726
ISSN 2162-402X
Short Title Pushing the boundaries of radiotherapy-immunotherapy combinations
Library Catalog PubMed
Extra PMID: 39696783
Tags Combined Modality Therapy, FLASH radiotherapy, Humans, immune checkpoint, immunorad, Immunotherapy, low-dose radiotherapy, lymph-node sparing, Neoplasms, Radiotherapy, T cells, tumor-associated macrophages
Date Added 2024/12/20 - 02:11:58
Date Modified 2024/12/20 - 02:11:58
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés